0000000000814370
AUTHOR
F. Fähndrich
Use of Mechanistic Information for Adequate Metabolic Design of Genotoxicity Studies and Toxicological Interactions of Drugs and Environmental Chemicals
Microorganisms as well as mammalian cells used for mutagenicity investigations have little or no activities for metabolism of premutagens and precarcinogens, i.e. of compounds ultimately leading to mutations and cancer but first requiring metabolic activation. Therefore, to such cells an exogenous activating system is added, generally the postmitochondrial supernatant fraction of the liver homogenate and a NADPH-generating system (Ames et al. 1976). In this situation enzymes requiring cofactors other than NADP(H) are unlikely to be active. Thus, this metabolic system is rather artificial. Monooxygenases are active in this system. They, for example, convert polycyclic aromatic hydrocarbons t…
Significance of Posttranslational Modification of Drug Metabolizing Enzymes by Phosphorylation for the Control of Carcinogenic Metabolites
The total activity of foreign compound metabolizing enzymes may change by altering the amount or the specific activity of the enzyme by induction or repression, or by activation or inhibition. The important contribution of enzyme induction is well known (Conney 1982, Oesch 1986, Nebert and Jones 1989). This is a relatively slow process which requires the biosynthesis of the enzyme protein. The possibility of a faster regulation of foreign compound metabolism by posttranslational modification by phosphorylation of an already preexisting protein molecule has only recently received attention. A central role in the metabolism of foreign compounds is played by the cytochrome P450-dependent monoo…